Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma

NCT03899649 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.

NCT NCT03899649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
Lead sponsor
Angiodynamics, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
May 8, 2019
Completion date
April 30, 2025
Enrollment
532 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii pancreatic cancer